Here is a concise listing of major cancer types, with epidemiology, diagnostic biomarkers, descriptions of genes for prognosis and therapy through biotarget-specific molecular treatments. Covers current debate on patentability of genetic information and more.
Read More
Here is a concise listing of major cancer types, with epidemiology, diagnostic biomarkers, descriptions of genes for prognosis and therapy through biotarget-specific molecular treatments. Covers current debate on patentability of genetic information and more.
Read Less
Add this copy of Biotargets of Cancer in Current Clinical Practice to cart. $215.66, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2012 by Humana.
Add this copy of Biotargets of Cancer in Current Clinical Practice to cart. $235.06, new condition, Sold by GreatBookPricesUK5 rated 4.0 out of 5 stars, ships from Castle Donington, DERBYSHIRE, UNITED KINGDOM, published 2012 by Humana.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 564 p. Contains: Unspecified, Tables, black & white. Current Clinical Pathology. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of Biotargets of Cancer in Current Clinical Practice to cart. $272.02, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2016 by Humana.
